Genomenon, Inozyme Pharma Partner to Advance Genetic Diagnosis for Rare Disease
A partnership between Genomenon and Inozyme Pharma will make variant data on ENPP1 deficiency available to genetic testing labs across the world.
Read MorePosted by Chris Wolski | Nov 11, 2021 | Company News |
A partnership between Genomenon and Inozyme Pharma will make variant data on ENPP1 deficiency available to genetic testing labs across the world.
Read MorePosted by Chris Wolski | Nov 10, 2021 | Molecular Diagnostic Analyzers |
Thermo Fisher Scientific has expanded its diagnostics portfolio to support full qPCR assay development and testing workflow.
Read MorePosted by Chris Wolski | Nov 9, 2021 | Prenatal Testing |
Sema4 and Mount Sinai collaborated on two studies that demonstrate how machine learning can be used to improve postpartum hemorrhage risk prediction.
Read MorePosted by Chris Wolski | Nov 8, 2021 | Covid 19, Sequencing Systems |
Developed by UC San Diego researchers, the SENSR tool is based on CRISPR gene-editing technology that allows speedy detection of pathogens by identifying genetic sequences in their DNA or RNA.
Read MorePosted by Chris Wolski | Nov 5, 2021 | Colorectal |
Phillips-Medisize provides end-to-end manufacturing support to Exact Sciences, developers of the FDA-approved Cologuard at-home colorectal screening test.
Read More